Stellular raised early-stage financing to advance its therapy candidate, STLR-201, into clinical testing for dry eyes caused by Sjögren's.
Source: google.com
Stellular raised early-stage financing to advance its therapy candidate, STLR-201, into clinical testing for dry eyes caused by Sjögren's.
Source: google.com